181 results on '"Gumbleton M"'
Search Results
2. Caveolin and its cellular and subcellular immunolocalisation in lung alveolar epithelium: implications for alveolar epithelial type I cell function
3. Influence of anaesthetics on renal function and drug deposition
4. Models of the alveolar epithelium
5. Downregulation and altered spatial pattern of caveolin-1 in chronic plaque psoriasis
6. The inhibition of phagocytosis of respirable microspheres by alveolar and peritoneal macrophages
7. Microcalorimetry does not predict the cellular phagocytosis of latex microspheres
8. Temporal dependence of ectopeptidase expression in alveolar epithelial cell culture: implications for study of peptide absorption
9. Organic Cation Transporter Expression and Activity in Human Respiratory Epithelial Cells.
10. Combined expression of caveolin-1 and an activated AKT/mTOR pathway predicts reduced disease-free survival in clinically confined renal cell carcinoma
11. A supplementary review format
12. Coming out of the dark: the evolving role of fluorescence imaging in drug delivery research
13. Caveolin-1 overexpression predicts poor disease-free survival of patients with clinically confined renal cell carcinoma
14. Lung surfactant phospholipids inhibit the uptake of respirable microspheres by the alveolar macrophage NR8383
15. Polylysine and Polyornithine Gene Transfer Complexes: A Study of Complex Stability and Cellular Uptake as a Basis for their Differential in-vitro Transfection Efficiency
16. Statistical Modelling of the Formulation Variables in Non-Viral Gene Delivery Systems
17. Synthesis, Anti-Human Immunodeficiency Virus Activity and Esterase Lability of Some Novel Carboxylic Ester-Modified Phosphoramidate Derivatives of Stavudine (d4T)
18. Immunocytochemical examination of alveolar type I epithelial cell transport vesicles
19. Pharmacokinetic-pharmacodynamic (PK-PD) modelling in non-steady-state studies and arterio-venous drug concentration differences.
20. Pharmacological activity of the dinitrate metabolites of nitroglycerin following their oral administration to healthy volunteers [letter]
21. In-vivo effects of itraconazole on hepatic mixed-function oxidase.
22. Caveolae and the caveolins in human disease
23. Caveolae as potential macromolecule trafficking compartments within alveolar epithelium
24. Examination of the biophysical interaction between plasmid DNA and the polycations, polylysine and polyornithine, as a basis for their differential gene transfection in-vitro
25. Physical stability and in-vitro gene expression efficiency of nebulised lipid-peptide-DNA complexes
26. Gene expression in an intact ex-vivo skin tissue model following percutaneous delivery of cationic liposome-plasmid DNA complexes
27. The renin-angiotensin system and intraperitoneal toxicity: Possible basis to urethane anaesthesia-induced reductions in renal clearance in the rat
28. High-resistance monolayers of primary isolated human alveolar epithelial cells: Expression of P-glycoprotein and caveolin-1
29. Rat Renal Tubule Fragments: A Sensitive Preparation for the Study of Drug Induced Nephrotoxicity
30. INTERACTION OF CYCLOSPORIN AND ITRACONAZOLE
31. Dose-response and time-response biochemical and histological study of potassium dichromate-induced nephrotoxicity in the rat
32. Principles in the absorption, distribution and elimination of pharmaceuticals
33. Urethane anaesthesia: altered pharmacokinetics of the renally eliminated organic anion p-aminohippuric acid
34. TTF-1 and immune checkpoint therapy in non-small cell lung cancer.
35. A phase I open-label study of the safety and efficacy of apatinib (rivoceranib) administered to patients with advanced malignancies to improve sensitivity to pembrolizumab in the second- or later-line setting (APPEASE).
36. Topical, immunomodulatory epoxy-tiglianes induce biofilm disruption and healing in acute and chronic skin wounds.
37. Local delivery to malignant brain tumors: potential biomaterial-based therapeutic/adjuvant strategies.
38. Caveolin-1, a Key Mediator Across Multiple Pathways in Glioblastoma and an Independent Negative Biomarker of Patient Survival.
39. Zwitterionic self-assembled nanoparticles as carriers for Plasmodium targeting in malaria oral treatment.
40. Quantifying the effects of antibiotic treatment on the extracellular polymer network of antimicrobial resistant and sensitive biofilms using multiple particle tracking.
41. Satellitosis , a Crosstalk between Neurons, Vascular Structures and Neoplastic Cells in Brain Tumours; Early Manifestation of Invasive Behaviour.
42. Humidified Warmed CO 2 Treatment Therapy Strategies Can Save Lives With Mitigation and Suppression of SARS-CoV-2 Infection: An Evidence Review.
43. Heparin-based, injectable microcarriers for controlled delivery of interleukin-13 to the brain.
44. Poly(ethylene glycol) based nanotubes for tuneable drug delivery to glioblastoma multiforme.
45. Auto-fluorescent PAMAM-based dendritic molecules and their potential application in pharmaceutical sciences.
46. A human co-culture cell model incorporating microglia supports glioblastoma growth and migration, and confers resistance to cytotoxics.
47. Oral Immunogenicity in Mice and Sows of Enterotoxigenic Escherichia Coli Outer-Membrane Vesicles Incorporated into Zein-Based Nanoparticles.
48. Mannosylated Nanoparticles for Oral Immunotherapy in a Murine Model of Peanut Allergy.
49. Self-emulsifying drug delivery system: Mucus permeation and innovative quantification technologies.
50. Modulation of the fate of zein nanoparticles by their coating with a Gantrez® AN-thiamine polymer conjugate.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.